Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Tollenaere

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmacy World & Science : PWS|April 1, 1996
The role of structure-based ligand design and molecular modelling in drug discoveryJ P Tollenaere
Bioorganic & Medicinal Chemistry|March 1, 1997
Possible ligand-receptor interactions for NK1 antagonists as observed in their crystal structuresG J Boks, J P Tollenaere, J Kroon
Journal of Computer-Aided Molecular Design|June 1, 1990
CGEMA and VGAP: a Colour Graphics Editor for Multiple Alignment using a variable GAP penalty. Application to the muscarinic acetylcholine receptorH Moereels, L De Bie, J P Tollenaere
European Journal of Pharmacology|June 1, 1977
Differentiation of opiate and neuroleptic receptor binding in rat brainJ Leysen, J P Tollenaere, M H Koch, et al.
Thrombosis Research|December 1, 1985
Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pHF De Clerck, B Xhonneux, J P Tollenaere, et al.
European Journal of Pharmacology|August 8, 1998
Structure-activity relationships of astemizole derivatives for inhibition of store operated Ca2+ channels and exocytosisM J Fischer, J J Paulussen, J P Tollenaere, et al.
Journal of Medicinal Chemistry|February 2, 1996
In vivo activity and hydrophobicity of cytostatic aziridinyl quinonesE E Moret, M de Boer, H W Hilbers, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmacy World & Science : PWS|April 1, 1996
The role of structure-based ligand design and molecular modelling in drug discoveryJ P Tollenaere
Bioorganic & Medicinal Chemistry|March 1, 1997
Possible ligand-receptor interactions for NK1 antagonists as observed in their crystal structuresG J Boks, J P Tollenaere, J Kroon
Journal of Computer-Aided Molecular Design|June 1, 1990
CGEMA and VGAP: a Colour Graphics Editor for Multiple Alignment using a variable GAP penalty. Application to the muscarinic acetylcholine receptorH Moereels, L De Bie, J P Tollenaere
European Journal of Pharmacology|June 1, 1977
Differentiation of opiate and neuroleptic receptor binding in rat brainJ Leysen, J P Tollenaere, M H Koch, et al.
Thrombosis Research|December 1, 1985
Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pHF De Clerck, B Xhonneux, J P Tollenaere, et al.
European Journal of Pharmacology|August 8, 1998
Structure-activity relationships of astemizole derivatives for inhibition of store operated Ca2+ channels and exocytosisM J Fischer, J J Paulussen, J P Tollenaere, et al.
Journal of Medicinal Chemistry|February 2, 1996
In vivo activity and hydrophobicity of cytostatic aziridinyl quinonesE E Moret, M de Boer, H W Hilbers, et al.
Pageof 1